Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

November 15, 2025

Study Completion Date

April 30, 2026

Conditions

CKDLow Protein Dietary Intake

Interventions

DIETARY_SUPPLEMENT

Renalive® LP, flavour Vanilla

flavour Vanilla

DIETARY_SUPPLEMENT

Renalive® LP, flavour Cappuccino

flavour Cappuccino

Trial Locations (1)

Taipei Tzu Chi Hospital, New Taipei City